Tag Archives: Vaccine

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised November 5th, 2024Luz Ponce

CDC Recommends Second Dose of 2024-2025 COVID-19 Vaccine for People 65 Years and Older and for People Who are Moderately or Severely Immunocompromised

November 5, 2024News & Updates20242025, COVID19, Dose, Immunocompromised, Moderately, Older, People, Recommends, second, Severely, Vaccine, yearsLuz Ponce

Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for people 65 years and older and those who are moderately or severely immunocompromised to receive a second dose of 2024-2025 COVID-19 vaccine six months after their first dose.

CDC Study Finds Flu Vaccine Saves Children's Lives – Press Release June 2nd, 2024Deborah Sibley

CDC Study Finds Flu Vaccine Saves Children's Lives – Press Release

June 2, 2024News & UpdatesChildren&#039s, Finds, lives, Press, Release, saves, Study, VaccineDeborah Sibley

A new CDC study published today in Pediatrics is the first of its kind to show that flu vaccination significantly reduced a child’s risk of dying from influenza.

Level 1 – Meningococcal Disease in Saudi Arabia – Vaccine Requirements for Travel During the Hajj and Umrah Pilgrimages May 23rd, 2024Mellisa Robie

Level 1 – Meningococcal Disease in Saudi Arabia – Vaccine Requirements for Travel During the Hajj and Umrah Pilgrimages

May 23, 2024News & UpdatesArabia, Disease, During, Hajj, Level, Meningococcal, Pilgrimages, Requirements, Saudi, Travel, Umrah, VaccineMellisa Robie

The Hajj, or pilgrimage to Mecca, Saudi Arabia, is one of the world’s largest mass gatherings. Mass gatherings, such as Hajj or Umrah, can increase the risk for infections such as meningococcal disease.

U.S.-licensed yellow fever vaccine supply to be depleted by mid-2017 – Media Statement May 3rd, 2024Julie Dreher

U.S.-licensed yellow fever vaccine supply to be depleted by mid-2017 – Media Statement

May 3, 2024News & Updatesdepleted, Fever, Media, mid2017, Statement, Supply, U.S.licensed, Vaccine, YellowJulie Dreher

The Centers for Disease Control and Prevention outlines a plan to ensure a continuous yellow fever vaccine supply in the United States following the anticipated depletion of the U.S.-licensed YF-VAX® yellow fever vaccine in mid-2017,

CDC finalizes vaccine recommendation for adults traveling to areas with cholera – Media Statement April 15th, 2024Edith Ballou

CDC finalizes vaccine recommendation for adults traveling to areas with cholera – Media Statement

April 15, 2024News & Updatesadults, areas, Cholera, finalizes, Media, recommendation, Statement, Traveling, VaccineEdith Ballou

The Centers for Disease Control and Prevention’s recommendation for the use of a cholera vaccine in adults traveling to areas with cholera is now final.

Older Adults Now Able to Receive Additional Dose of Updated COVID-19 Vaccine March 1st, 2024Lawrence Picklesimer

Older Adults Now Able to Receive Additional Dose of Updated COVID-19 Vaccine

March 1, 2024News & Updatesable, Additional, adults, COVID19, Dose, Older, Receive, Updated, VaccineLawrence Picklesimer

Today, CDC Director Mandy Cohen endorsed the CDC Advisory Committee on Immunization Practices’ (ACIP) recommendation for adults ages 65 years and older to receive an additional updated 2023-2024 COVID-19 vaccine dose.

Most U.S. teens are getting cancer-preventing vaccine – Press Release January 31st, 2024Deana Bowman

Most U.S. teens are getting cancer-preventing vaccine – Press Release

January 31, 2024News & Updatescancerpreventing, Getting, Most, Press, Release, Teens, U.S., VaccineDeana Bowman

Six out of 10 U.S. parents are choosing to get the human papillomavirus (HPV) vaccine for their children, according to a report published in this week’s Morbidity and Mortality Weekly Report.

Physicians for Informed Consent Files Amicus Curiae Brief with Supreme Court of the United States to End Vaccine Mandates for Schoolchildren January 19th, 2024Thomas Barnhart

Physicians for Informed Consent Files Amicus Curiae Brief with Supreme Court of the United States to End Vaccine Mandates for Schoolchildren

January 19, 2024News & UpdatesAmicus, Brief, Consent, Court, Curiae, Files, Informed, Mandates, Physicians, Schoolchildren, States, Supreme, United, VaccineThomas Barnhart

Newport Beach, California – Physicians for Informed Consent (PIC), a 501(c)(3) nonprofit educational organization focused on science and statistics, has filed an amicus curiae brief in support of Connecticut parents’ right of informed refusal to vaccinate their schoolchildren in the case We The Patriots USA v. Connecticut Office Of Early Childhood Development (United States Supreme Court … Continue reading Physicians for Informed Consent Files Amicus Curiae Brief with Supreme Court of the United States to End Vaccine Mandates for Schoolchildren →

Just Over Half of Adults with Work-Related Asthma Report Having Received a Pneumococcal Vaccine – Press Release December 21st, 2023Judith Glover

Just Over Half of Adults with Work-Related Asthma Report Having Received a Pneumococcal Vaccine – Press Release

December 21, 2023News & Updatesadults, Asthma, Half, Having, Just, Over, Pneumococcal, Press, received, Release, Report, Vaccine, WorkRelatedJudith Glover

Adults with asthma are at increased risk for pneumococcal disease, yet according to a new CDC study published today in the American Journal of Preventive Medicine,

CDC recommends new vaccine to help protect babies against severe respiratory syncytial virus (RSV) illness after birth October 3rd, 2023Nicolas Kennedy

CDC recommends new vaccine to help protect babies against severe respiratory syncytial virus (RSV) illness after birth

October 3, 2023News & UpdatesAfter, Against, Babies, Birth, help, illness, protect, Recommends, respiratory, severe, syncytial, Vaccine, virusNicolas Kennedy

Today, CDC recommended the first respiratory syncytial virus (RSV) vaccine for pregnant people to protect their newborn from severe RSV illness. RSV is the leading cause of hospitalization for U.S. infants. This new vaccine, Pfizer’s bivalent RSVpreF vaccine (trade name Abrysvo TM), has been shown to reduce the risk of RSV hospitalization for babies by … Continue reading CDC recommends new vaccine to help protect babies against severe respiratory syncytial virus (RSV) illness after birth →